Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Warren Ellsworth

Plastic Surgery Houston, TX Medical Doctor

NPI 1336470343 CMS profile 150843

6560 Fannin St, Suite 2200, Houston, TX 77030

Open in the dashboard

General payments

$284,477

389 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$74,466 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Warren Ellsworth of Houston, TX is reported in the CMS Open Payments database as having received $284,477 across 389 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $74,466 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,212 50
2024 General $7,779 24
2023 General $60,003 58
2022 General $81,092 71
2021 General $53,617 85
2020 General $16,902 32
2019 General $34,872 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Warren Ellsworth
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Warren Ellsworth were reported at $30,212. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Warren Ellsworth Plastic Surgery median Middle half National median
2019 $34,872 $371 $122–$1,483 $163
2020 $16,902 $158 $52–$438 $114
2021 $53,617 $249 $87–$752 $132
2022 $81,092 $274 $102–$793 $149
2023 $60,003 $299 $113–$891 $160
2024 $7,779 $361 $124–$1,062 $164
2025 $30,212 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $152,061 138 payments
  2. AbbVie, Inc. $56,417 51 payments
  3. AxoGen $48,440 59 payments
  4. Integra LifeSciences Corporation $9,500 13 payments
  5. Sientra, Inc. $7,079 18 payments
  6. Mentor Worldwide LLC $1,776 31 payments
  7. Motiva USA, LLC $1,537 10 payments
  8. Merz North America, Inc. $1,358 6 payments
  9. Biocircuit Technologies Inc $1,250 2 payments
  10. Tepha Inc $1,075 14 payments
  11. Other $3,986 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $143,775 52 payments
  2. Consulting Fee $85,176 39 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $21,600 2 payments
  4. Food and Beverage $21,280 255 payments
  5. Travel and Lodging $12,560 40 payments
  6. Gift $87 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $139,019 112 payments
  2. AXOGUARD NERVE PROTECTOR $47,004 46 payments
  3. AxoGuard Nerve Connector $47,004 46 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $35,122 24 payments
  5. REVOLVE $31,135 31 payments
  6. Avance Nerve Graft $27,599 25 payments
  7. NATRELLE $15,998 30 payments
  8. ALLODERM $10,883 15 payments
  9. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $7,079 18 payments
  10. SURGIMEND $6,654 7 payments
  11. Other $28,898 160 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$39

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

0%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 12 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$29,906

Medicare's payments for the services billed

Medicare patients

27

Average age 72

Services billed

61

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Cancer 59%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $213
$213 — —
BOTOX
  • AbbVie, Inc. $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

389 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record